Evidence map›Paper›PMID 35039333›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2022

The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population.

Michael K Tu, Samantha H Chiang, Richard A Bender, David T W Wong, Charles M Strom

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Saliva diagnostics: Salivaomics, saliva exosomics, and saliva liquid biopsy.Journal of the American Dental Association (1939) · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Michael K TuLiquid Diagnostics LLC, San Clemente, CA; and.ORCID 0000-0002-7227-4030
Samantha H ChiangUCLA School of Dentistry, Los Angeles, CA.
Richard A BenderLiquid Diagnostics LLC, San Clemente, CA; and.
David T W WongUCLA School of Dentistry, Los Angeles, CA.
Charles M StromLiquid Diagnostics LLC, San Clemente, CA; and strom@liquid-dx.com.ORCID 0000-0001-9709-0724

Funding

UC BRAID Center for Accelerated Innovation COVID-19 diagnostic project developmentU54HL119893 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PALAZZOLO, MICHAEL J · 2013 to 2020
$18.3M
AFS/SERS Saliva-based SARS-CoV-2 Earliest Infection and Antibodies DetectionU18TR003778 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HUANG, TONY JUN, KIM, YONG · 2021 to 2022
$1.8M
Immunoregulatory role of saliva polymeric IgA1 in the pathogenesis of primary Sjögren’s SyndromeR03DE030990 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2021 to 2022
$312k
NCATS NIH HHS U18 TR003778NHLBI NIH HHS U54 HL119893NIDCR NIH HHS R03 DE030990
6 · The paper itself

Abstract

We used a noninvasive electrochemical quantitative assay for IgG Abs to SARS-CoV-2 S1 Ag in saliva to investigate the kinetics of Ab response in a community-based population that had received either the Pfizer or Moderna mRNA-based vaccine. Samples were received from a total of 97 individuals, including a subset of 42 individuals who collected samples twice weekly for 3 mo or longer. In all, >840 samples were collected and analyzed. In all individuals, salivary SARS-CoV-2 S1 IgG Ab levels rose sharply in the 2-wk period after their second vaccination, with peak Ab levels seen at 10-20 d after vaccination. We observed that 20%, 10%, and 2.4% of individuals providing serial samples had a 90%, 95%, and 99% drop, respectively, from peak levels during the duration of monitoring, and in two patients, Abs fell to prevaccination levels (5%). The use of noninvasive quantitative salivary Ab measurement can allow widespread, cost-effective monitoring of vaccine response.

Indexed as

2019-nCoV Vaccine mRNA-1273AdultAge FactorsAntibodies, ViralBNT162 VaccineCommunity-Based Participatory ResearchCOVID-19FemaleHumansImmunoglobulin GMaleSalivaSARS-CoV-2Vaccination2019-nCoV Vaccine mRNA-1273Antibodies, ViralBNT162 VaccineImmunoglobulin G

Identifiers

PMID35039333
PMCPMC8827620
OpenAlexW4225815694

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.